I-5-Bromo-2-Cyanopyridine CAS 97483-77-7 Ubunyulu ≥99.0% (HPLC) Tedizolid Phosphate Intermediate
Ubonelelo lwabavelisi, ubunyulu obuphezulu, iMveliso yoRhwebo
Igama leKhemikhali: 5-Bromo-2-Cyanopyridine
CAS: 97483-77-7
Igama leMchiza | 5-Bromo-2-Cyanopyridine |
Izithethantonye | 5-Bromo-2-Pyridinecarbonitrile;5-Bromopicolinonitrile |
Inombolo yeCAS | 97483-77-7 |
Inombolo yeCAT | RF-PI610 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | I-C6H3BrN2 |
Ubunzima beMolekyuli | 183.01 |
Indawo yokunyibilika | 128.0~132.0℃ (ilayiti.) |
Indawo yokubilisa | 100.0-110.0℃/3 mmHg (lit.) |
Ukunyibilika | Inyibilika kwiMethanol |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Okumhlophe-kumhlophe ukuya kumgubo oNtuthulu oMthubi |
Ubunyulu / Indlela yokuHlalutya | ≥99.0% (HPLC) |
Ukufuma (KF) | ≤0.50% |
Ukungcola ngokupheleleyo | ≤1.0% |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | Umbindi weTedizolid Phosphate (CAS: 856867-55-5) |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi.
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma.
I-5-Bromo-2-Cyanopyridine (i-CAS: 97483-77-7) i-organic synthesis kunye ne-pharmaceutical intermediate, enokusetyenziswa kakhulu kuphando lwebhubhoratri kunye nenkqubo yokuvelisa imichiza.I-5-Bromo-2-Cyanopyridine iphakathi kweTedizolid Phosphate (CAS: 856867-55-5).I-Tedizolid Phosphate lichiza elitsha le-anti-bacterial eliphuhliswe yinkampani ye-CUBIST PHARMS.I-Tedizolid phosphate liyeza leTedizolid.Emva kokulawulwa komlomo okanye nge-intravenous, i-Tedizolid phosphate iguqulelwa kwi-Tedizolid nge-phosphatase.I-Tedizolid sisizukulwana sesibini se-oxazolidinone antibiotics, iprotheni synthesis inhibitors.ukubopha i-50S subunit ye-ribosomes yebhaktheriya, inokuthintela ukuhlanganiswa kweprotheni kwaye idlale indima ye-antibacterial.Ngomhla wama-20 kuJuni, i-2014, i-US Food and Drug Administration (i-FDA) ivume i-Tedizolid phosphate ukuba isetyenziswe kwi-bacterial-induced acute acute bacterial skin and skin structure infections (ABSSSI), enegama lokurhweba elithi SIVEXTRO.